Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NEU2 | Q9Y3R4 | 8/20 | 0.34 |
| ▸ | NEU1 | Q99519 | 8/20 | 0.33 |
| ▸ | NEU4 | Q8WWR8 | 6/20 | 0.32 |
| ▸ | NEU3 | Q9UQ49 | 6/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17448411 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NEU2NEU1NEU4NEU3 | |
| SCHEMBL23233747 | 0.83 | L3MBTL1 (0.36) | L3MBTL1NEU2NEU1NEU4NEU3 | |
| SCHEMBL17447095 | 0.82 | L3MBTL1 (0.41) | L3MBTL1NEU2NEU1NEU4NEU3 | |
| SCHEMBL19106880 | 0.82 | L3MBTL1 (0.41) | L3MBTL1NEU2NEU1NEU4NEU3 | |
| SCHEMBL15491954 | 0.79 | — | — | |
| SCHEMBL14669264 | 0.78 | L3MBTL1 (0.36) | L3MBTL1NEU2NEU1NEU4NEU3 | |
| SCHEMBL29842099 | 0.77 | NEU2 (0.49) | L3MBTL1NEU2NEU1NEU4NEU3 | |
| SCHEMBL24630056 | 0.77 | NEU1 (0.40) | L3MBTL1NEU2NEU1NEU4NEU3 | |
| SCHEMBL24418448 | 0.77 | NEU2 (0.49) | L3MBTL1NEU2NEU1NEU4NEU3 | |
| SCHEMBL17297667 | 0.77 | NEU2 (0.49) | L3MBTL1NEU2NEU1NEU4NEU3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4489791-A1 | ANTI-GD2 ANTIBODIES, IMMUNOCONJUGATES AND THERAPEUTIC USES THEREOF | Merck Patent GmbH (DE) | 2025-01-15 | — | — | EP | disclosed |
| WO-2023172968-A1 | ANTI-GD2 ANTIBODIES, IMMUNOCONJUGATES AND THERAPEUTIC USES THEREOF | MERCK PATENT GMBH (DE) | 2023-09-14 | — | — | WO | disclosed |
| CN-114901294-A | Bispecific antibody CAR cellular immunotherapy | 赛通免疫治疗公司 | 2022-08-12 | — | — | CN | disclosed |